In NSCLC, inhibition of GAS5 expression resulted in chemoresistance due to the competition between GAS5 and PTEN for miR-21 binding, regarding the tumor-suppressor activity of PTEN as a negative regulator of the AKT/PKB signaling pathway [129]. This evidence concerns the gene PTEN and non-small cell lung carcinoma.